● Self-Produced raw material
- High quality Saccharin comes from the high purity raw material
- JMC’s R&F Process requires OTSA (Ortho-Toluenesulfonamide) as a raw material, while other processes use a different raw material, PA (Phthalic Anhydride) that is more prone to forming impurities during reactions. JMC is one of the few companies in the world to produce OTSA and our completely vertically integrated process enables us to control the purity at every step.
● Global Standard
- Saccharin complies with all Pharmacopoeias & Food Standards
- JMC Saccharin conforms to all Pharmacopoeias & Food standards (USP/NF, FCC, JECFA, EP, E954, JP, KP etc.). Currently all global standards are identifying and rating the quality of Saccharin based on JMC’s material. JMC saccharin is the global standard. JMC Saccharin is free from any allergen, irradiation, pesticides, GMO, BSE/TSE, gluten, latex and lactose even though these are not all regulated in the current Pharmacopoeias.
In their annual report, the USP Council of Experts have highlighted their current review of saccharin regulations. Catherine M. Sheehan, M.S., M.S. Senior Director, Science – Excipients, USP, is quoted (page 15):
Most people don’t think much about excipients, which are considered the ‘inactive’ ingredients in medicine. But these are actually critically important to how well a drug works in the body, as well as how it tastes if it’s oral medication. And they can cause great harm to patients if their quality is poor, so we are very proud of the work we do to help ensure the quality of excipients. We published draft standards seeking comments from international stakeholders revising the standards for three types of saccharin. Today, saccharin is used to help make medicines—which would otherwise taste pretty bad—palatable for patients. It is also used as an excipient for medications delivered intravenously or by aerosol, which means it’s critical to control impurities. This work is important because we know that saccharin may contain about 10 impurities that can develop during some manufacturing processes, including a few that can be harmful. This is part of our work with the Pharmacopeial Discussion Group, which includes USP, the European Pharmacopoeia, and the Japanese Pharmacopoeia, to harmonize excipient monographs and general test methods in order to align standards to bring more efficiency in quality testing.